Our Vitals product has undergone initial validation through internal validation studies, in alignment with medical device regulatory standards. This forms part of our structured approach to ensuring compliance, safety, and efficacy. We are actively enhancing the product and preparing for a more stringent phase of clinical trials, adhering to recognised industry protocols. As we continue to refine our product, we are seeking collaboration with qualified research partners to conduct external clinical trials that will further validate product's performance, safety, and efficacy. This process reflects our ongoing commitment to regulatory compliance and ensures our Vitals product meets the highest standards of safety and accuracy, minimising any potential risks and reinforcing public confidence.